MPI Research Breaks Ground on New Imaging Center - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

MPI Research Breaks Ground on New Imaging Center

MPI Research, in partnership with INVICRO and 3D Imaging, held the groundbreaking for its new Imaging Center, which is set to open in Spring 2014 at the MPI Research corporate headquarters in Mattawan, Michigan. Pharmaceutical researchers will have access to a cyclotron facility directly connected to vivarium, permitting drug radiolabeling and in-depth studies across a variety of animal models.

The 10,000 ft2, two-story imaging center is the latest joint effort between MPI, INVICRO, and 3D Imaging, which have collaborated on more than 100 imaging projects to date. The multimillion-dollar project will include INVICRO’s molecular imaging informatics team and 3D Imaging’s radiopharmaceutical group.

Many of the expanded imaging solutions, including nonhuman primate PET and CT imaging capabilities, became available in July 2013.

Source: MPI Research


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here